Pages that link to "Q50790013"

The following pages link to A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization (Q50790013):

Displaying 40 items.

• Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction (Q24187850) (← links)
• Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction (Q24234909) (← links)
• Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF) (Q24248615) (← links)
• Different ovarian stimulation protocols for women with diminished ovarian reserve (Q24634342) (← links)
• Gonadotropin-releasing hormone analogs: Understanding advantages and limitations (Q27022451) (← links)
• Use of luteinizing hormone releasing hormone agonists in polycystic ovary syndrome (Q33812567) (← links)
• Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques (Q33872072) (← links)
• Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles (Q33909718) (← links)
• Expression pattern of endothelin system components and localization of smooth muscle cells in the human pre-ovulatory follicle (Q34815638) (← links)
• Alternative approaches in the management of poor response in controlled ovarian hyperstimulation (COH). (Q35596221) (← links)
• Contemporary pharmacological manipulation in assisted reproduction (Q35660963) (← links)
• Incomplete androgen and progesterone suppression following midluteal GnRHa prior to controlled ovarian hyperstimulation for IVF-ET (Q36267966) (← links)
• Management of the poor responder: the role of GnRH agonists and antagonists (Q36268626) (← links)
• Adverse effects of induced hot flashes on objectively recorded and subjectively reported sleep: results of a gonadotropin-releasing hormone agonist experimental protocol (Q36941470) (← links)
• Nocturnal Hot Flashes: Relationship to Objective Awakenings and Sleep Stage Transitions (Q37033359) (← links)
• Microdose follicular flare: a viable alternative for normal-responding patients undergoing in vitro fertilization? (Q37116986) (← links)
• A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep (Q37301954) (← links)
• Comparison of the ultrashort gonadotropin-releasing hormone agonist-antagonist protocol with microdose flare -up protocol in poor responders: a preliminary study (Q37611176) (← links)
• Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study (Q39221821) (← links)
• Gonadotrophin-releasing hormone agonists. A guide to use and selection (Q40394336) (← links)
• Treatment of low responders (Q40828934) (← links)
• Significance of an abnormal response during pituitary desensitization in an in vitro fertilization and embryo transfer program (Q40940732) (← links)
• Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women (Q43553933) (← links)
• Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates (Q43844381) (← links)
• Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization–embryo transfer (Q44442541) (← links)
• Clinical outcome of using ganirelix acetate versus a 4-day follicular phase leuprolide acetate protocol in unselected women undergoing in vitro fertilization (Q44505656) (← links)
• Correlation between steroid hormonal levels and cardiac function in women during controlled ovarian hyperstimulation (Q45423271) (← links)
• The influence of supraphysiologic estradiol levels on human nidation (Q46087191) (← links)
• Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders (Q48683632) (← links)
• Exogenous gonadotropin stimulation is associated with increases in serum androgen levels in in-vitro fertilization-embryo transfer cycles (Q48948436) (← links)
• Prematurely condensed chromosomes and meiotic abnormalities in unfertilized human oocytes after ovarian stimulation with and without gonadotropin-releasing hormone agonist (Q48959026) (← links)
• Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization (Q48959041) (← links)
• Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome (Q49041288) (← links)
• Type of stimulation protocol affects oocyte maturity, fertilization rate, and cleavage rate after intracytoplasmic sperm injection (Q49041355) (← links)
• Comparison of cycle outcome for gamete intrafallopian transfer alone and in combination with intrauterine embryo transfer (Q49156404) (← links)
• The effect of the duration of GnRH-agonist down regulation before ovarian stimulation on the biological and clinical outcome after intracytoplasmic sperm injection (Q50741220) (← links)
• Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis (Q70911752) (← links)
• A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotropin-releasing hormone in an in vitro fertilization program (Q71556254) (← links)
• Comparative analysis of the effects of gonadotropin-releasing hormone agonist on the proliferative activity, apoptosis, and steroidogenesis in cultured porcine granulosa cells at varying stages of follicular growth (Q73899958) (← links)
• Prospective comparison of short and long GnRH agonist protocols using recombinant gonadotrophins for IVF/ICSI treatments (Q81310033) (← links)